Celgene Corp (CELG) Misses Q4 EPS by 1c, Sales Fall Just Short
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CELG Hot Sheet
Price: $108.24 --0%
Financial Fact:
Income before income taxes: 256.8M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Income before income taxes: 256.8M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Celgene Corp (NASDAQ: CELG) reported Q4 EPS of $1.05, $0.01 worse than the analyst estimate of $1.06. Revenue for the quarter came in at $1.24 billion versus the consensus estimate of $1.29 billion.
For earnings history and earnings-related data on Celgene Corp (CELG) click here.
For earnings history and earnings-related data on Celgene Corp (CELG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CPS Technologies (CPSH) Reports In-Line Q3 EPS
- Caterpillar shares fall amid analyst downgrades
- Abbvie (ABBV) PT Raised to $340 at BMO Capital
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
